IRIS Registry data shows which patients respond to laser trabeculoplasty.
For moderately ill hospitalized patients with COVID-19, tocilizumab is not effective for preventing intubation or death.
Researchers assessed the impact Tocilizumab had on patients with non-infectious uveitis and found that the antibody reduced inflammation in eyes with the disease.
Researchers sought to describe the frequency of ocular flares in patients with non-infectious uveitis who switch from originator infliximab to biosimilar infliximab.
Between one-fifth and one-third of patients with rheumatoid arthritis, connective tissue disease, and vasculitis have ocular complications.
Researchers addressed the genetic association between juvenile idiopathic arthritis-associated uveitis and idiopathic pediatric uveitis.